Anafranil
Active ingredient: Clomipramine
Delivery: from 4 days
- Worldwide Delivery4-7 business days
- Quality GuaranteedOnly original products
- Bonus pillsSave up to 80%
- 24/7 SupportOur team of pharmacists is available 24/7 to help you
Anafranil tablets are taken by mouth for conditions such as obsessive-compulsive disorder and selected mood or anxiety disorders. They contain clomipramine hydrochloride, a tricyclic antidepressant that changes serotonin and noradrenaline signalling in the brain. The dose and schedule depend on the purpose of treatment, age, formulation and response.
Product information
Anafranil contains clomipramine hydrochloride, the hydrochloride form of clomipramine. It belongs to the tricyclic antidepressant class.
Active Ingredient and Pharmacological Class
Clomipramine is a serotonin reuptake inhibitor with additional effects on noradrenaline pathways. Serotonin is a chemical messenger involved in mood, anxiety, impulse control and repetitive thoughts. Noradrenaline contributes to alertness, attention and emotional regulation.
The tablet form is swallowed by mouth. Anafranil belongs to the same broad family as other tricyclic antidepressants, though its strong serotonin activity makes it distinct within that group.
How it affects the body
Clomipramine blocks the reuptake of serotonin between nerve cells. More serotonin remains available in the synaptic space, allowing repeated signalling between neurons. This action is linked with improvement in obsessive thoughts, compulsive behaviours, anxiety and depressive symptoms, although no single mechanism explains every clinical response.
Serotonin Reuptake Inhibition
The serotonin effect develops gradually.
Active Metabolite and Neurotransmitter Effects
Clomipramine is converted into desmethylclomipramine, an active metabolite that has stronger effects on noradrenergic signalling. This helps explain why Anafranil can influence alertness, heart rate, blood pressure and sleep as well as serotonin-related symptoms.
The active metabolite can also contribute to prolonged effects after a dose. Drug interactions may therefore remain relevant during a transition between antidepressants. Pharmacology references describe this combined serotonergic and noradrenergic activity as a defining feature of clomipramine [2].
Ingredients
Anafranil contains clomipramine hydrochloride, the hydrochloride form of clomipramine. It belongs to the tricyclic antidepressant class.
Dosage and administration
- Dose: Take the prescribed amount of Anafranil in mg; the dose depends on the purpose of treatment, age, formulation and response.
- Frequency: Take it at the times per day prescribed by the doctor or pharmacist.
- Timing: Take the tablets by mouth with water, at the prescribed time of day. Follow any meal instructions provided for your regimen.
- Duration: Continue treatment for the duration prescribed. Do not increase the dose or stop treatment suddenly without medical guidance.
- Route: Swallow the tablets by mouth.
When not to use it
Anafranil is not suitable for people taking monoamine oxidase inhibitors, or MAOIs. Combining clomipramine with an MAOI can cause severe toxicity. The relevant medicines include phenelzine, also known as Nardil, and isocarboxazid, also known as Marplan.
MAOI Contraindication and Washout Periods
A planned transition between an MAOI and clomipramine requires a clinician-directed washout period. The interval depends on the previous medicine, its half-life, the patient’s condition and the proposed treatment.
Contraindications and Clinical Review
Anafranil is not for you if you have a known allergy to clomipramine or another tricyclic antidepressant, or if you are currently taking an MAOI. A prescriber also needs to review the treatment carefully when there is:
- Epilepsy or a previous seizure.
- Bipolar disorder or past mania.
- Heart rhythm disease, fainting or significant cardiovascular disease.
- Narrow-angle glaucoma.
- Urinary retention or prostate-related difficulty passing urine.
- Severe liver disease.
- Pregnancy or breastfeeding.
- A history of suicidal thinking.
When this is not for you
Anafranil is not suitable for everyone. A history of seizures, heart rhythm problems, glaucoma, urinary retention, bipolar disorder or troublesome interactions can change the treatment decision.
Do not begin Anafranil after stopping an MAOI without a clear prescriber-led plan. The same applies in reverse.
Alcohol may intensify drowsiness, dizziness, impaired coordination and poor judgement caused by clomipramine. Avoid alcohol until a prescriber or pharmacist confirms that it is appropriate for your treatment plan.
Possible side effects
Anafranil can cause anticholinergic, gastrointestinal, neurological, cardiovascular and sexual side effects. Common problems include dry mouth, nausea, indigestion, constipation, dizziness and sleepiness. Impotence or reduced libido can also occur.
Common Anticholinergic and Gastrointestinal Effects
Dry mouth results from reduced salivary secretion. Frequent sips of water, sugar-free gum and careful oral hygiene may make it easier to manage. Persistent dryness can contribute to dental problems.
Constipation may improve with suitable fluids, fibre and movement when these measures fit the person’s health needs. Severe abdominal pain, repeated vomiting or several days without a bowel movement needs prompt medical attention.
Nausea and indigestion may be more noticeable when treatment begins. Taking the tablet with food can help some patients, though severe vomiting can affect treatment continuity and requires medical advice.
Sedation, Dizziness and Sexual Effects
Sleepiness and dizziness may impair driving, cycling, coordination and work with machinery. Stand up slowly from a chair or bed, especially during dose increases. Alcohol can intensify these effects.
Sexual dysfunction may include reduced desire, delayed orgasm or impotence. It is a recognised treatment issue and should be discussed openly rather than managed by abruptly stopping Anafranil.
Serious Reactions and Seizure Risk
Urgent medical help is needed for:
- A seizure or loss of consciousness.
- Fainting, severe palpitations or a markedly irregular heartbeat.
- Severe confusion, extreme agitation or a sudden change in behaviour.
- New suicidal thoughts or impulses to self-harm.
- Severe allergic symptoms, facial swelling or difficulty breathing.
- High fever, heavy sweating, tremor, diarrhoea and muscle rigidity.
- Severe eye pain with blurred vision.
- Inability to urinate.
Seizure risk can rise with overdose, abrupt dose changes, a seizure disorder and certain interacting medicines. Anafranil toxicity may also affect cardiac conduction, so fainting or an abnormal heartbeat should never be dismissed as an ordinary side effect.
Therapeutic indications
Its main established use is obsessive-compulsive disorder, or OCD, a condition involving intrusive thoughts and repetitive behaviours that feel difficult to control. FDA prescribing information describes clomipramine as a treatment for OCD, while other uses depend on clinical judgement and local approval [1].
Approved and Clinician-Directed Uses
Anafranil may be prescribed for:
- Obsessive-compulsive disorder, its principal established indication.
- Major depressive disorder or depression in selected clinical situations.
- Panic disorder when a prescriber considers its risk-benefit profile appropriate.
- Premature ejaculation, sometimes as an off-label treatment under medical supervision.
- Narcolepsy-related symptoms in selected cases, depending on the treatment plan.
These conditions are not interchangeable. A person taking Anafranil for OCD may require a different treatment strategy from someone receiving it for depression or panic disorder. Premature ejaculation and narcolepsy-related use require an individual assessment because other treatment options may be preferred.
Comparison
Clomipramine is the generic name of the active substance in Anafranil. A product containing clomipramine may be therapeutically comparable only when its strength, release type, dosage form and regulatory status are appropriately matched.
| Treatment category | Active substance | Switching consideration |
|---|---|---|
| Anafranil or clomipramine generic | Clomipramine | Formulation and strength must match before substitution |
| Related tricyclic antidepressant | Imipramine | Related class, but not an automatic equivalent |
| Serotonergic antidepressant category | Various substances | Different interaction and side-effect profiles |
A clomipramine generic is not automatically interchangeable with every clomipramine product. Sustained-release and immediate-release forms may produce different exposure patterns.
Imipramine is another tricyclic antidepressant, but it contains a different active substance. It should not be substituted for clomipramine without a prescriber-led plan. The same principle applies to switching from a tricyclic antidepressant to an SSRI or SNRI.
Common mistakes
Common mistakes include:
- Stopping Anafranil abruptly after feeling better.
- Doubling the next dose after a missed tablet.
- Starting an SSRI, SNRI or serotonergic supplement without mentioning Anafranil.
- Drinking alcohol while still assessing sedation.
- Driving before understanding the effect on reaction time.
- Changing from immediate-release tablets to Anafranil S.R independently.
- Crushing or chewing a modified-release tablet.
- Hiding sexual side effects from the prescriber.
- Assuming a related tricyclic antidepressant is an automatic replacement.
Sudden cessation may produce withdrawal-like symptoms and allow OCD, anxiety or depressive symptoms to return. Persistent but non-urgent side effects often lead clinicians to adjust timing or dose. Severe reactions require urgent assessment rather than a routine medication adjustment.
What doctors say
In clinical practice, prescribers usually set expectations before treatment begins. Anafranil may reduce obsessive thoughts and compulsive behaviours, yet improvement often develops more slowly than early side effects. A gradual titration plan can improve tolerability.
A doctor will usually ask about sleepiness, constipation, urination, sexual function, mood changes, dizziness and palpitations. These details help distinguish manageable effects from symptoms requiring a dose change or urgent assessment.
Follow-up also examines whether the original diagnosis remains the best explanation for the symptoms. Panic, depression, OCD and narcolepsy-related symptoms can overlap, but they do not always respond to the same treatment strategy.
Common questions
Can Anafranil be combined with antidepressants or serotonin supplements?
Clomipramine requires careful review when combined with SSRIs, SNRIs, buspirone, serotonergic pain medicines or mood supplements. FDA safety information and antidepressant interaction guidance available in 2024 describe serotonin toxicity symptoms such as agitation, sweating, tremor, fever and muscle rigidity. The risk is also affected by the previous medicine’s half-life and metabolism. A prescriber should direct any combination or transition. Follow-up should assess symptom change and adverse effects.
How soon can Anafranil’s effect become noticeable?
Side effects such as nausea, sleepiness or dry mouth may appear before improvement in OCD, depression or panic symptoms. Clinical guidance from NICE reviewed in 2022 describes antidepressant response as gradual and supports follow-up when symptoms remain severe or worsen. Anafranil should not be judged after a single dose. The treatment plan may need adjustment if benefit remains limited or adverse effects are difficult to tolerate.
What should be discussed with a doctor before starting Anafranil?
Discuss seizures, heart rhythm problems, fainting, glaucoma, urinary retention, bipolar disorder, pregnancy, breastfeeding and suicidal thoughts. WHO medication-safety principles published in 2023 support a complete review of prescription medicines, non-prescription products and supplements before starting a centrally acting drug. Mention every antidepressant taken recently, especially an MAOI, fluoxetine or another serotonergic medicine. The treatment purpose also needs to be clear because OCD, depression, panic disorder and off-label uses may require different plans.
Which symptoms require stopping and seeking urgent medical help?
A seizure, fainting, severe palpitations, difficulty breathing, facial swelling, severe confusion or new suicidal thoughts requires urgent medical attention. FDA antidepressant safety information reviewed in 2024 also identifies severe agitation, fever, sweating, tremor and muscle rigidity as warning symptoms of serotonin toxicity. Do not take extra tablets to compensate for symptoms or alter the schedule while waiting for help. Emergency services are appropriate for loss of consciousness, breathing difficulty or suspected overdose.
Is Anafranil suitable for older adults?
Older adults may be more sensitive to sleepiness, dizziness, constipation, urinary retention, confusion and heart rhythm effects. Geriatric prescribing principles from the American Geriatrics Society in 2023 support careful review of anticholinergic medicines in older people. Falls, memory changes or new difficulty passing urine should be reported promptly. The prescriber may choose slower titration and closer review based on kidney, liver, cardiac and neurological health.
What should happen after a missed Anafranil dose?
The correct action depends on how close the missed dose is to the next scheduled dose and whether the tablet is immediate-release or sustained-release. NHS medicines guidance reviewed in 2024 advises avoiding double doses unless a prescriber has specifically instructed otherwise. If the next dose is near, the missed dose is commonly skipped rather than repeated. Ask the dispensing pharmacist or prescriber for product-specific instructions when timing is uncertain, especially after missing more than one dose.
Do you offer anonymous delivery?
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Comparison
Sources
- U.S. Food and Drug Administration (2018). Anafranil (clomipramine hydrochloride) Capsules Prescribing Information.
- National Center for Biotechnology Information (2023). Clomipramine — StatPearls.